Does GOLIMUMAB Cause Benign prostatic hyperplasia? 14 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Benign prostatic hyperplasia have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 0.0% of all adverse event reports for GOLIMUMAB.
14
Reports of Benign prostatic hyperplasia with GOLIMUMAB
0.0%
of all GOLIMUMAB reports
3
Deaths
11
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From GOLIMUMAB?
Of the 14 reports, 3 (21.4%) resulted in death, 11 (78.6%) required hospitalization.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which GOLIMUMAB Alternatives Have Lower Benign prostatic hyperplasia Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN